Immunotherapy for Uterine Cancer
A physician-evaluated, immune-based approach for patients diagnosed with uterine or endometrial cancer.
Uterine Cancer: Overview
Uterine cancer, including endometrial cancer, is commonly treated with surgery, radiation, chemotherapy, hormone therapy, targeted therapy, or immunotherapy depending on the stage, molecular profile, and disease progression. Many patients continue looking for additional options — especially when the disease is advanced, recurrent, or when standard treatment has not delivered the expected response.
NK Cell Immunotherapy offers a cellular approach designed to support the immune system's natural ability to identify and respond to abnormal cells.
"Uterine tissue has a unique relationship with immune regulation. Supporting NK cell function may offer an additional layer of immune engagement that complements established care."
Giostar Medical Team
Why early action is Critical
Uterine cancer is increasing in both incidence and mortality — making timely evaluation especially important.
expected u.s. cases
69,000
expected uterine cancer cases in the United States in a recent annual estimate. (American Cancer Society)
Annual u.s. deaths
14,000
deaths attributed to uterine cancer annually in the United States.
Advanced disease may affect
Energy and fatigue
Abnormal bleeding patterns
Pelvic comfort
Hormonal balance
Uterine cancer is increasing in both incidence and mortality. Delaying evaluation may reduce available options and allow the disease to become harder to manage.
Why Consider Cellular Immunotherapy?
Natural Killer cells are part of the innate immune system and play an important role in tumor surveillance. In uterine cancer, the immune environment is especially relevant because uterine tissue has a unique relationship with immune regulation. Research suggests that understanding NK cells in the uterine tumor microenvironment may support the development of NK-targeted therapeutic strategies.
Nk cell mechanism
How Natural Killer Cells Target Cancer
Tumor Cell
Cancer cells evade normal immune detection
NK Recognition
NK cells detect "missing self" signals on abnormal cells
Cytotoxic Release
NK cells deploy perforin and granzymes
Cell Elimination
Tumor cell undergoes targeted aproptosis
In the clinical program, NK cells are collected from the patient, expanded in a controlled laboratory setting, and reinfused under physician oversight — supporting the body's own immune targeting capacity.
NK Cell Therapy is designed to:
Support immune surveillance
Help the immune system recognize abnormal cells
Provide a systemic, whole-body immune approach
Complement a broader treatment strategy when medically appropriate
Are You a Candidate?
NK Cell Immunotherapy may be considered for patients who:
Have been diagnosed with uterine cancer or endometrial cancer
Are exploring complementary or integrative treatment options
Have advanced, recurrent, or metastatic disease
Have not responded as expected to conventional treatment
Want to support immune function during or after treatment
Are seeking a less invasive cellular therapy option
Every case is individually reviewed by our physician team to determine whether the patient is eligible.
Not all uterine cancer patients qualify for our program. Eligibility is determined individually through physician-led medical review. This page provides general educational context — not medical advice or a determination of suitability.
A Comprehensive Approach
Physician-led case review
In-house cellular laboratory processing
Nutritional support
International patient coordination
Clinical process
How the Process Works
Medical Evaluation
Your diagnosis, medical history, and treatment goals are reviewed by our physicians.
Immune Profiling & Blood Collection
A blood sample is collected to isolate immune cells and assess baseline function.
NK Cell Expansion
NK cells are activated and expanded in our specialized laboratory.
Controlled Reinfusion
Expanded NK cells are administered intravenously under clinical protocols.
Monitoring & Follow-Up
Progress is tracked through advanced laboratory testing and physician follow-up.
Next Step: Medical Review
If you or a family member has been diagnosed with breast cancer and is exploring additional options, the first step is to submit your case for physician review. Our team will assess your specific situation and respond with an eligibility determination.